MICHAEL PLASTOW: Open Payments
NPI 1366748873 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,469 in 130 payments from 17 companies in 2025. Trend: 2023 $2,047 · 2024 $2,371 · 2025 $2,469
Food & beverage: $2,461Education: $8
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 31 | $591 |
| CSL Behring | 23 | $499 |
| Novartis Pharmaceuticals Corporation | 13 | $240 |
| GENZYME CORPORATION | 10 | $200 |
| PFIZER INC. | 11 | $181 |
| GlaxoSmithKline, LLC. | 11 | $161 |
| Grifols USA, LLC | 7 | $139 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Optinose US, Inc. | 4 | $71 |
Products named: Hizentra, TEZSPIRE, DUPIXENT, Haegarda, NUCALA, FASENRA, CIBINQO, Andembry.
Industry payments across MO — which companies pay providers there.
